Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT
Adolescent
Adult
Angiotensin I
/ metabolism
Angiotensin II
/ metabolism
Angiotensin-Converting Enzyme 2
Black People
Humans
Hypertension
/ metabolism
Middle Aged
Peptide Fragments
/ metabolism
Peptides
/ metabolism
Peptidyl-Dipeptidase A
/ metabolism
Proto-Oncogene Mas
Proto-Oncogene Proteins
/ metabolism
Receptor, Angiotensin, Type 1
/ metabolism
Receptors, G-Protein-Coupled
/ metabolism
Renin-Angiotensin System
Young Adult
Afro-Caribbean
Renin angiotensin aldosterone system
angiotensin II
angiotensin-(1–7)
blood pressure
hypertension
Journal
Journal of the renin-angiotensin-aldosterone system : JRAAS
ISSN: 1752-8976
Titre abrégé: J Renin Angiotensin Aldosterone Syst
Pays: England
ID NLM: 100971636
Informations de publication
Date de publication:
Historique:
entrez:
25
2
2020
pubmed:
25
2
2020
medline:
24
11
2020
Statut:
ppublish
Résumé
Low plasma renin activity hypertension is prevalent in Afro-Caribbean persons. Reduced angiotensin converting enzyme 2 activity from the counter angiotensin converting enzyme 2 /angiotensin-(1-7)/Mas receptor axis of the renin angiotensin aldosterone system has been reported in people with pre-hypertension, type 2 diabetes mellitus and chronic renal disease. This study investigates whether an imbalance in the regulatory mechanisms between the pressor arm of the renin angiotensin aldosterone system (angiotensin converting enzyme/angiotensin II/AT1 receptor) and the depressor axis (angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor) predisposes persons of African descent to hypertension. In total, 30 normotensives and 30 recently diagnosed hypertensives aged 18-55 of Afro-Caribbean origin who are naïve to antihypertensive treatment will be recruited from public sector polyclinics in Barbados. Demographic and anthropometric data, clinical blood pressure readings, 24-hour urine collections and venous blood samples will be collected. Biological samples will be analysed for renin angiotensin aldosterone system peptide markers using radioimmunoassay. We describe the design, methods and rationale for the characterization of renin angiotensin aldosterone system mechanisms that may contribute to hypertension predisposition in persons of African descent. Our findings will characterize any imbalance in the counter axes of the renin angiotensin aldosterone system in hypertensive Afro-Caribbeans with a potential view of identifying novel approaches with the use of renin angiotensin aldosterone system and mineralocorticoid blockers to manage the condition.
Identifiants
pubmed: 32089050
doi: 10.1177/1470320320908186
pmc: PMC7036504
doi:
Substances chimiques
Peptide Fragments
0
Peptides
0
Proto-Oncogene Mas
0
Proto-Oncogene Proteins
0
Receptor, Angiotensin, Type 1
0
Receptors, G-Protein-Coupled
0
Angiotensin II
11128-99-7
Angiotensin I
9041-90-1
ACE protein, human
EC 3.4.15.1
Peptidyl-Dipeptidase A
EC 3.4.15.1
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
angiotensin I (1-7)
IJ3FUK8MOF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1470320320908186Subventions
Organisme : NIMHD NIH HHS
ID : U54 MD010711
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
Curr Med Res Opin. 2000;16(2):66-79
pubmed: 10893650
Hypertension. 2006 Mar;47(3):515-21
pubmed: 16365192
J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):539-46
pubmed: 24532825
Arch Intern Med. 2003 Mar 10;163(5):525-41
pubmed: 12622600
Am J Hypertens. 2017 May 1;30(5):478-483
pubmed: 28052878
Hypertension. 1991 Jan;17(1 Suppl):I122-8
pubmed: 1986989
Am J Hypertens. 1998 Feb;11(2):137-46
pubmed: 9524041
Nephrol Dial Transplant. 2007 Feb;22(2):597-601
pubmed: 17095582
Hypertension. 1996 Nov;28(5):854-8
pubmed: 8901834
Endocr Relat Cancer. 2016 Oct;23(10):R437-54
pubmed: 27485459
Clin Sci (Lond). 2014 Apr;126(7):461-9
pubmed: 24329563
Adv Pharmacol. 2010;59:197-233
pubmed: 20933203
Ther Adv Cardiovasc Dis. 2016 Jun;10(3):162-71
pubmed: 27105891
Circ Cardiovasc Genet. 2015 Feb;8(1):131-40
pubmed: 25477429
Eur J Prev Cardiol. 2019 Mar;26(5):455-457
pubmed: 30595049
J Hypertens. 2017 Dec;35(12):2380-2387
pubmed: 28786859
Hypertension. 2005 Oct;46(4):707-13
pubmed: 16172426
QJM. 2001 Jul;94(7):391-6
pubmed: 11435635
Ther Adv Cardiovasc Dis. 2013 Dec;7(6):293-305
pubmed: 24280597
Cardiovasc Drugs Ther. 1996 Nov;10(5):511-8
pubmed: 8950064
J Hum Hypertens. 2002 Apr;16(4):267-73
pubmed: 11967721
Front Cardiovasc Med. 2019 Nov 15;6:163
pubmed: 31803758
Am J Hypertens. 2002 Jun;15(6):557-64
pubmed: 12074359
Cell. 2001 Feb 23;104(4):545-56
pubmed: 11239411
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63
pubmed: 12829792
Ann Hum Genet. 2008 Jan;72(Pt 1):90-8
pubmed: 17908263
Hypertension. 2018 Aug;72(2):263-269
pubmed: 29941519
Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1560-6
pubmed: 15951342
Kidney Int. 2008 Dec;74(12):1610-6
pubmed: 19034303
J Hypertens. 1996 Jun;14(6):799-805
pubmed: 8793704
J Nephrol. 1998 Nov-Dec;11(6):278-83
pubmed: 10048492
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H404-14
pubmed: 27233763
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Hypertension. 2019 May;73(5):e35-e66
pubmed: 30827125